Reduced FOXP3+ regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms

Journal of Hepatology

Volumn 60, Issue 5, 2014, Pages 1010-1016

  Sebode, Marcial ^a   Peiseler, Moritz ^a   Franke, Björn ^a   Schwinge, Dorothee ^a   Schoknecht, Tanja ^a   Wortmann, Frederike ^a   Quaas, Alexander ^a   Petersen, Britt Sabina ^b   Ellinghaus, Eva ^b   Baron, Udo ^c   Olek, Sven ^c   Wiegard, Christiane ^a   Weiler Normann, Christina ^a   Lohse, Ansgar W ^a   Herkel, Johannes ^a   Schramm, Christoph ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c EPIONTIS GMBH   (Germany)

Author keywords

Cholangitis; IL2RA; Immune regulation; Primary sclerosing cholangitis; Treg

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IL2RA PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR ALPHA;

ADULT; AGED; BLOOD; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; FEMALE; GENETICS; HOMOZYGOTE; HUMAN; IMMUNOLOGY; LIVER; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; REGULATORY T LYMPHOCYTE; SCLEROSING CHOLANGITIS; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CHOLANGITIS, SCLEROSING; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HOMOZYGOTE; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LIVER; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 84898828520     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.12.027     Document Type: Article

References (30)

1. G.M. Hirschfield, T.H. Karlsen, K.D. Lindor, and D.H. Adams Primary sclerosing cholangitis Lancet 382 2013 1587 1599
2. European Association for the Study of the Liver EASL Clinical Practice Guidelines: management of cholestatic liver diseases J Hepatol 51 2009 237 267
3. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance Immunol Rev 182 2001 18 32
4. +CD25+ T cell suppressor function J Immunol 172 2004 6519 6523
5. W. Hsu, W. Zhang, K. Tsuneyama, Y. Moritoki, W.M. Ridgway, and A.A. Ansari et al. Differential mechanisms in the pathogenesis of autoimmune cholangitis vs. inflammatory bowel disease in interleukin-2Ralpha(-/-) mice Hepatology 49 2009 133 140
6. E. Melum, A. Franke, C. Schramm, T.J. Weismüller, D.N. Gotthardt, and F.A. Offner et al. Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci Nat Genet 43 2011 17 19
7. M. Janse, L.E. Lamberts, L. Franke, S. Raychaudhuri, E. Ellinghaus, and K. Muri Boberg et al. Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9 Hepatology 53 2011 1977 1985
8. + regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency J Hepatol 57 2012 125 132
9. U. Baron, S. Floess, G. Wieczorek, K. Baumann, A. Grützkau, and J. Dong et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells Eur J Immunol 37 2007 2378 2389
10. G. Wieczorek, A. Asemissen, F. Model, I. Turbachova, S. Floess, and V. Liebenberg et al. Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue Cancer Res 69 2009 599 608
11. J.Z. Liu, J.R. Hov, T. Folseraas, E. Ellinghaus, S.M. Rushbrook, and N.T. Doncheva et al. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis Nat Genet 45 2013 670 675
12. G.A. Thorisson, A.V. Smith, L. Krishnan, and L.D. Stein The international HapMap project web site Genome Res 15 2005 1592 1593
13. K. Ishak, A. Baptista, L. Bianch, F. Callea, J. De Groote, and F. Gudat et al. Histological grading and staging of chronic hepatitis J Hepatol 22 1995 696 699
14. C. Asseman, S. Mauze, M.W. Leach, R.L. Coffman, and F. Powrie An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation J Exp Med 190 1999 995 1004
15. + regulatory T cells Proc Natl Acad Sci U S A 106 2009 13439 13444
16. T.H. Karlsen, A. Franke, E. Melum, A. Kaser, J.R. Hov, and T. Balschun et al. Genome-wide association analysis in primary sclerosing cholangitis Gastroenterology 138 2010 1102 1111
17. J.R. Hov, V. Kosmoliaptsis, J.A. Traherne, M. Olsson, K.M. Boberg, and A. Bergquist et al. Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis Hepatology 53 2011 1967 1976
18. T.R. Malek, and I. Castro Interleukin-2 receptor signaling: at the interface between tolerance and immunity Immunity 33 2010 153 165
19. L. Barron, H. Dooms, K.K. Hoyer, W. Kuswanto, J. Hofmann, and W.E. O'Gorman et al. Cutting edge: mechanisms of IL-2-dependent maintenance of functional regulatory T cells J Immunol 185 2010 6426 6430
20. K. Wakabayashi, Z.X. Lian, Y. Moritoki, R.Y. Lan, K. Tsuneyama, and Y.H. Chuang et al. IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis Hepatology 44 2006 1240 1249
21. R.Y. Lan, C. Cheng, Z.X. Lian, K. Tsuneyama, G.X. Yang, and Y. Moritoki et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis Hepatology 43 2006 729 737
22. F. Bernuzzi, D. Fenoglio, F. Battaglia, M. Fravega, M.E. Gershwin, and F. Indiveri et al. Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis J Autoimmun 35 2010 176 180
23. G.M. Hirschfield, and M.E. Gershwin The immunobiology and pathophysiology of primary biliary cirrhosis Annu Rev Pathol 8 2013 303 330
24. M.E. Himmel, Y. Yao, P.C. Orban, T.S. Steiner, and M.K. Levings Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers Immunology 136 2012 115 122
25. Y.H. Oo, C.J. Weston, P.F. Lalor, S.M. Curbishley, D.R. Withers, and G.M. Reynolds et al. Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver J Immunol 184 2010 2886 2898
26. Y. Zen, T. Fujii, K. Harada, M. Kawano, K. Yamada, and M. Takahira et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis Hepatology 45 2007 1538 1546
27. M. Koyabu, K. Uchida, H. Miyoshi, Y. Sakaguchi, T. Fukui, and H. Ikeda et al. Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases J Gastroenterol 45 2010 732 741
28. D.N. Abarbanel, S.M. Seki, Y. Davies, N. Marlen, J.A. Benavides, and K. Cox et al. Immunomodulatory effect of vancomycin on Treg in pediatric inflammatory bowel disease and primary sclerosing cholangitis J Clin Immunol 33 2013 397 406
29. Y.H. Oo, and D.H. Adams Regulatory T cells and autoimmune hepatitis: defective cells or a hostile environment? J Hepatol 57 2012 6 8
30. J. Katt, D. Schwinge, T. Schoknecht, A. Quaas, I. Sobottka, and E. Burandt et al. Increased Th17 response to pathogen stimulation in patients with primary sclerosing cholangitis Hepatology 58 2013 1084 1093